Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome (HIDS): results from an open-label study

被引：0
|
作者：
JI Aróstegui
J Anton
I Calvo
A Robles
A Speziale
Y Joubert
G Junge
J Yagüe
机构：
[1] Hospital Clinic,
[2] Hospital Sant Joan de Déu,undefined
[3] Hospital La Fe,undefined
[4] Hospital La Paz,undefined
[5] Novartis Pharma AG,undefined
[6] Hospital Clinic,undefined
来源：
Pediatric Rheumatology | / 13卷 / Suppl 1期
关键词：
Withdrawal Period; Canakinumab; Periodic Fever Syndrome; Global Assessment Score; HIDS Patient;
D O I：
10.1186/1546-0096-13-S1-O58
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH HIDS (HYPER-IGD SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Oommen, P.
    Kallinich, T.
    Rech, J.
    Blank, N.
    Weber-Arden, J.
    Kuemmerle-Deschner, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1978 - 1978
  • [2] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH HIDS (HYPER-IGD SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Oommen, P.
    Kallinich, T.
    Rech, J.
    Blank, N.
    Weber-Arden, J.
    Kuemmerle-Deschner, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1027 - 1028
  • [3] FINAL ANALYSIS OF STUDY OF EFFICACY AND SAFETY OF CANAKINUMAB IN ACTIVE HYPER-IGD SYNDROME
    Arostegui, J. I.
    Anton, J.
    Calvo, I.
    Robles, A.
    Speziale, A.
    Joubert, Y.
    Junge, G.
    Yague, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 401 - 401
  • [4] CANAKINUMAB TREATMENT OF PATIENTS WITH HYPER-IGD SYNDROME: AN OPEN-LABEL, MULTICENTER, PILOT STUDY
    Anton, J.
    Calvo, I.
    Robles, A.
    Yaguee, J.
    Arostegui, J.
    Viana, R.
    Tseng, L.
    Abrams, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 329 - 330
  • [5] Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: Results from an Open-Label Long-Term Followup Study
    Brunner, Hermine L.
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Schneider, Rayfel
    Kone-Paut, Isabelle
    Schikler, Kenneth
    Marzan, Katherine
    Wulffraat, Nico
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Speziale, Antonio
    Lheritier, Karine
    Vritzali, Eleni
    Lovell, Daniel J.
    Martini, Alberto
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [6] Long-term safety and efficacy of canakinumab in cryopyrin-associated periodic syndrome: results from an open-label, phase III pivotal study in Japanese patients
    Yokota, S.
    Imagawa, T.
    Nishikomori, R.
    Takada, H.
    Abrams, K.
    Lheritier, K.
    Heike, T.
    Hara, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (06) : S19 - S26
  • [7] Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis: Results From an Open-Label, Long-Term Follow-up Study
    Brunner, Hermine
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Schneider, Rayfel
    Kone-Paut, Isabelle
    Schikler, Kenneth N.
    Marzan, Katherine
    Wulffraat, Nico
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Speziale, Antonio
    Lheritier, Karine
    Vritzali, Eleni
    Martini, Alberto
    Lovell, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 7 - 8
  • [8] ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
    Cohen, Stanley
    Pablos, Jose L.
    Zhang, Nan
    Rizzo, Warren
    Muller, Gerhard
    Padmanaban, Devi
    Kivitz, Alan
    Matsumoto, Alan K.
    Kaur, Primal
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [9] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Banerji, A.
    Hao, J.
    Yu, M.
    Bernstein, J.
    Johnston, D.
    Riedl, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S21 - S21
  • [10] Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study
    Iwata, Naomi
    Nishimura, Kenichi
    Hara, Ryoki
    Imagawa, Tomoyuki
    Shimizu, Masaki
    Tomiita, Minako
    Umebayashi, Hiroaki
    Takei, Syuji
    Seko, Noriko
    Wakabayashi, Ryota
    Yokota, Shumpei
    MODERN RHEUMATOLOGY, 2023, 33 (06) : 1162 - 1170
12345